Scotiabank analyst Patrick Colville maintains Oracle (NYSE:ORCL) with a Sector Outperform and raises the price target from $350 to $360.
AIM ImmunoTech CEO To Participate In Two Upcoming Investor Conferences
AIM ImmunoTech Inc. (NYSE:AIM) today announced that Thomas Equels, Chief Executive Officer of AIM, will be participating in two upcoming investor conferences.
BioFlorida Conference
Mr. Equels will be participating in